BRIEF-Immunitybio Strengthens Balance Sheet With $100 Million Of Financing Transactions Including $75 Million Of Non-Dilutive Financing To Support Global Expansion And Advancement Of Broader Immunotherapy Pipeline

ImmunityBio Inc +2.37% Post

ImmunityBio Inc

IBRX

7.78

7.77

+2.37%

-0.13% Post

Immunitybio Inc IBRX.O:

  • IMMUNITYBIO STRENGTHENS BALANCE SHEET WITH $100 MILLION OF FINANCING TRANSACTIONS INCLUDING $75 MILLION OF NON-DILUTIVE FINANCING TO SUPPORT GLOBAL EXPANSION AND ADVANCEMENT OF BROADER IMMUNOTHERAPY PIPELINE

Source text: ID:nBwbZTXGsa

Further company coverage: IBRX.O